ATP-binding cassette transporters in immortalised human brain microvascular endothelial cells in normal and hypoxic conditions

Experimental and Translational Stroke Medicine

Volumn 4, Issue 1, 2012, Pages

  Lindner, Christian ^a   Sigrüner, Alexander ^a   Walther, Franziska ^a   Bogdahn, Ulrich ^a   Couraud, Pierre O ^b,c   Schmitz, Gert ^a   Schlachetzki, Felix ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b CNRS   (France)

^c INSTITUT COCHIN   (France)

Author keywords

ABC transporters; Blood brain barrier; Hypoxia inducible factor; Ischemia reperfusion injury; Multidrug resistance; Stroke

Indexed keywords

ABC TRANSPORTER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 6; RNA;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; CELL IMMORTALIZATION; CELL LYSATE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; MITOCHONDRION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84867127572     PISSN: None     EISSN: 20407378     Source Type: Journal    
DOI: 10.1186/2040-7378-4-9     Document Type: Article

References (49)

1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
2. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857. 10.1161/STROKEAHA.108.534503, 19265055.
3. Heo JH, Han SW, Lee SK. Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 2005, 39:51-70. 10.1016/j.freeradbiomed.2005.03.035, 15925278.
4. Eisert WG, Schlachetzki F. Chapter 10 Vascular endothelium and the blood-brain barrier. Handb Clin Neurol 2008, 92:197-214.
5. del Zoppo GJ. The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci 2010, 1207:46-49. 10.1111/j.1749-6632.2010.05760.x, 20955425.
6. Pardridge WM. Blood-brain barrier biology and methodology. J Neurovirol 1999, 5:556-569. 10.3109/13550289909021285, 10602397.
7. Pillai DR, Dittmar MS, Baldaranov D, Heidemann RM, Henning EC, Schuierer G, Bogdahn U, Schlachetzki F. Cerebral ischemia-reperfusion injury in rats-a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 2009, 29:1846-1855. 10.1038/jcbfm.2009.106, 2848453, 19654585.
8. Kuroiwa T, Ting P, Martinez H, Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol (Berl) 1985, 68:122-129.
9. Kastrup A, Groschel K, Ringer TM, Redecker C, Cordesmeyer R, Witte OW, Terborg C. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke 2008, 39:2385-2387. 10.1161/STROKEAHA.107.505420, 18556588.
10. Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, El-Zammar Z, Alam S, Hallenbeck JM, Kidwell CS, Warach S. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 2010, 41:e123-e128. 10.1161/STROKEAHA.109.570515, 2827673, 20035078.
11. Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005, 6:591-602.
12. Pardridge WM, Boado RJ, Farrell CR. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 1990, 265:18035-18040.
13. Schlachetzki F, Pardridge WM. P-glycoprotein and caveolin-1alpha in endothelium and astrocytes of primate brain. Neuroreport 2003, 14:2041-2046. 10.1097/00001756-200311140-00007, 14600494.
14. Staud F, Pavek P. Breast cancer resistance protein (BCRP/ABCG2). Int J Biochem Cell Biol 2005, 37:720-725. 10.1016/j.biocel.2004.11.004, 15694832.
15. Dean M, Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 2005, 6:123-142. 10.1146/annurev.genom.6.080604.162122, 16124856.
16. Dean M, Allikmets R. Complete characterization of the human ABC gene family. J Bioenerg Biomembr 2001, 33:475-479. 10.1023/A:1012823120935, 11804189.
17. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001, 42:1007-1017.
18. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992, 8:67-113. 10.1146/annurev.cb.08.110192.000435, 1282354.
19. Loscher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2005, 2:86-98. 10.1602/neurorx.2.1.86, 539326, 15717060.
20. Hermann DM, Kilic E, Spudich A, Kramer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 2006, 60:489-498. 10.1002/ana.21012, 17048260.
21. Kilic E, Spudich A, Kilic U, Rentsch KM, Vig R, Matter CM, Wunderli-Allenspach H, Fritschy JM, Bassetti CL, Hermann DM. ABCC1: a gateway for pharmacological compounds to the ischaemic brain. Brain 2008, 131:2679-2689. 10.1093/brain/awn222, 18796513.
22. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 2006, 9:487-488. 10.1038/nn1676, 16565717.
23. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
24. Patak P, Jin F, Schafer ST, Metzen E, Hermann DM. The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells. Exp Transl Stroke Med 2011, 3:12. 10.1186/2040-7378-3-12, 3213079, 22029974.
25. Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Scherrmann JM, De Waziers I, Decleves X. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol 2009, 77:897-909. 10.1016/j.bcp.2008.11.001, 19041851.
26. Poller B, Gutmann H, Krahenbuhl S, Weksler B, Romero I, Couraud PO, Tuffin G, Drewe J, Huwyler J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 2008, 107:1358-1368. 10.1111/j.1471-4159.2008.05730.x, 19013850.
27. Langmann T, Mauerer R, Schmitz G. Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin Chem 2006, 52:310-313.
28. Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 2007, 17:265-273. 10.1097/CMR.0b013e3282a7e0b9, 17885581.
29. Dorovini-Zis K, Prameya R, Bowman PD. Culture and characterization of microvascular endothelial cells derived from human brain. Lab Invest 1991, 64:425-436.
30. Cecchelli R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer VV, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999, 36:165-178. 10.1016/S0169-409X(98)00083-0, 10837714.
31. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Liaw CW, Manning K, Morales J, et al. A cell culture model of the blood-brain barrier. J Cell Biol 1991, 115:1725-1735. 10.1083/jcb.115.6.1725, 2289219, 1661734.
32. Callahan MK, Williams KA, Kivisakk P, Pearce D, Stins MF, Ransohoff RM. CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer. J Neuroimmunol 2004, 153:150-157. 10.1016/j.jneuroim.2004.05.004, 15265673.
33. Gu X, Zhang J, Brann DW, Yu FS. Brain and retinal vascular endothelial cells with extended life span established by ectopic expression of telomerase. Invest Ophthalmol Vis Sci 2003, 44:3219-3225. 10.1167/ivos.02-0852, 12824274.
34. Muruganandam A, Herx LM, Monette R, Durkin JP, Stanimirovic DB. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J 1997, 11:1187-1197.
35. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 1997, 76:81-90. 10.1016/S0165-5728(97)00036-2, 9184636.
36. Carl SM, Lindley DJ, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Mol Pharm 2010, 7:1057-1068. 10.1021/mp900178j, 2914114, 20524699.
37. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008, 107:1518-1528. 10.1111/j.1471-4159.2008.05720.x, 19094056.
38. Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, Mayberg MR, Bengez L, Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001, 42:1501-1506.
39. Hermann DM, Bassetti CL. Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol Sci 2007, 28:128-134. 10.1016/j.tips.2007.01.007, 17275929.
40. Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP, Keppler D. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004, 129:349-360. 10.1016/j.neuroscience.2004.07.051, 15501592.
41. Xiao-Dong L, Zhi-Hong Y, Hui-Wen Y. Repetitive/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro. Neurosci Lett 2008, 432:184-187. 10.1016/j.neulet.2007.12.017, 18241990.
42. Felix RA, Barrand MA. P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J Neurochem 2002, 80:64-72. 10.1046/j.0022-3042.2001.00660.x, 11796744.
43. Robertson SJ, Kania KD, Hladky SB, Barrand MA. P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation. J Neurochem 2009, 111:132-141. 10.1111/j.1471-4159.2009.06306.x, 19656260.
44. Dazert P, Suofu Y, Grube M, Popa-Wagner A, Kroemer HK, Jedlitschky G, Kessler C. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats. Neuroscience 2006, 142:1071-1079. 10.1016/j.neuroscience.2006.07.056, 16997484.
45. del Zoppo GJ. Stroke and neurovascular protection. N Engl J Med 2006, 354:553-555. 10.1056/NEJMp058312, 16467542.
46. Yang L, Shah KK, Abbruscato TJ. An in vitro model of ischemic stroke. Methods Mol Biol 2012, 814:451-466. 10.1007/978-1-61779-452-0_30, 22144325.
47. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med 2006, 12:433-440. 10.1038/nm1390, 2740734, 16550187.
48. Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 2009, 40:604-609. 10.1161/STROKEAHA.108.522409, 2744391, 19023097.
49. Robertson SJ, Mokgokong R, Kania KD, Guedj AS, Hladky SB, Barrand MA. Nitric oxide contributes to hypoxia-reoxygenation-induced p-glycoprotein expression in rat brain endothelial cells. Cell Mol Neurobiol 2011, 31:1103-1111. 10.1007/s10571-011-9711-4, 21618049.